Rockland Immunochemicals Acquires Epi-Plus® Product Line

News   Apr 09, 2013

 
Rockland Immunochemicals Acquires Epi-Plus® Product Line
 
 
 

RELATED ARTICLES

Fabric Genomics Partners to Improve Pediatric Care

News

Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.

READ MORE

Edico Genome and Fabric Genomics Develop Integrated Solution for Genomics Analysis

News

Industry leaders partner to provide streamlined variant data analysis solution, with the goal of improving clinical care.

READ MORE

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News

Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE